| phoenixpharmex01@gmail.com |
| Business Type | Exporter, Supplier, Trader, Distributor |
| Packaging Type | 60 Tablet(s) In A Bottle |
| Country of Origin | India |
| Manufacturer | Zydus Cadila |
| Click to view more | |
Product Details
Ibyra 150mg Olaparib Tablet is a prescription targeted anti-cancer medication used in the treatment of certain BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. It contains Olaparib, a PARP (poly ADP-ribose polymerase) inhibitor that works by preventing cancer cells from repairing damaged DNA, leading to their destruction and helping to slow cancer progression. Ibyra 150mg Tablet is commonly prescribed as maintenance therapy or as part of a comprehensive treatment plan for eligible patients. Taken orally under the supervision of an oncology specialist, it requires regular monitoring to assess treatment effectiveness and manage potential side effects. Patients should use Ibyra 150mg Olaparib Tablet only as prescribed by their healthcare provider and attend all recommended follow-up appointments during treatment.
Raise your Query
Hi! Simply click below and type your query.
Our experts will reply you very soon.